Fluoxetine treatment of depressed patients with comorbid anxiety disorders

Journal of Psychopharmacology

Volumn 16, Issue 3, 2002, Pages 215-219

  Sonawalla, Shamsah B ^a   Farabaugh, Amy ^a   Johnson, Mary W ^a   Morray, Meridith ^a   Delgado, Margarita L ^a   Pingol, Mark G ^a   Rosenbaum, Jerrold F ^a   Fava, Maurizio ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Anxiety; Comorbid anxiety disorder; Fluoxetine; Major depression; Open trial

Indexed keywords

DESIPRAMINE; FLUOXETINE; IMIPRAMINE; LITHIUM; PAROXETINE; PHENELZINE; PSYCHOTROPIC AGENT; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ANGER; ANXIETY NEUROSIS; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG RESPONSE; FEMALE; GASTROINTESTINAL DISEASE; HAMILTON SCALE; HOSTILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSESSION; OUTPATIENT; OUTPATIENT CARE; PANIC; PREDICTION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; QUESTIONNAIRE; REMISSION; SCORING SYSTEM; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0036729278     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988110201600304     Document Type: Article

References (44)

1. High-dose fluoxetine: Efficacy and activating-sedating effects in agitated and retarded depression
2. An inventory for measuring clinical anxiety: Psychometric properties
3. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders
4. Symptom Questionnaire anxiety and depression scales: Reliability and validity
5. Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study
6. The safety of fluoxetine - An update
7. A double-blind comparative study of fluoxetine and dothiepin in the treatment of depression in general practice
8. Fluoxetine in post-traumatic stress disorder
9. National Institute of Mental Health Treatment of Depression Collaborative Research Program - General effectiveness of treatments
10. Major depressive subtypes and treatment response
11. Anxiety disorders in major depression
12. Fluoxetine versus sertraline and paroxetine in major depression: Tolerability and efficacy in anxious depression
13. Clinical management - Imipramine/placebo administration manual
14. A double-blind comparison of fluoxetine, imipramine, and placebo in outpatients with major depression
15. A rating scale for depression
16. The overlap between depression and anxiety on different levels of psychopathology
17. Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder
18. A symptom questionnaire
19. Treatment of social phobia with drugs other than benzodiazepines
20. Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder
21. Use of low-dose fluoxetine in major depression and panic disorder
22. Anxious depression
23. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline
24. Symptom-specific effects of fluoxetine in post-traumatic stress disorder
25. Brain fluoxetine measurements using fluorine magnetic resonance spectroscopy in patients with social phobia
26. The efficacy of fluoxetine as an antidepressant in the short and long term
27. A comparative clinical trial of fluoxetine, mianserin, and placebo in depressed outpatients
28. Fluoxetine in panic disorder: Pharmacologic and tritiated platelet imipramine and paroxetine binding study
29. Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders
30. Long-term treatment of obsessive-compulsive disorder after an acute response: A comparison of fluoxetine versus placebo
31. Suicidal ideation in major depression: Sex differences and impact of comorbid anxiety
32. Fluoxetine in panic disorder
33. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder
34. Placebo effects. Issues for clinical practice in psychiatry and medicine
35. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features
36. Medication side effects in anxious patients: Negative placebo responses?
37. Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication
38. Fluoxetine efficacy in social phobia
39. Fluoxetine in post-traumatic stress disorder
40. Pharmacotherapy of obsessive compulsive disorder - Experience with fluoxetine
41. The symptom questionnaire: British standardization data